Back to Diagnostic Members (DG)
Bioscience Company Member
Organization Overview
Depression and anxiety often go undetected until it’s too late. We are bringing the first point-of-care biology-based screening test to market for anxiety and depression.
We’re on a mission to address untreated mental illness in the United States, affecting 58 million Americans and costing the economy over $300 billion annually. By modeling prevention efforts for physical disease, we want to equip doctors and caregivers with an early warning system to improve outcomes.
We’re on a mission to address untreated mental illness in the United States, affecting 58 million Americans and costing the economy over $300 billion annually. By modeling prevention efforts for physical disease, we want to equip doctors and caregivers with an early warning system to improve outcomes.
Bioscience Company Member